Literature DB >> 8662889

Specific uncoupling of GRB2 from the Met receptor. Differential effects on transformation and motility.

C Ponzetto1, Z Zhen, E Audero, F Maina, A Bardelli, M L Basile, S Giordano, R Narsimhan, P Comoglio.   

Abstract

The biological effects of hepatocyte growth factor/scatter factor are mediated by autophosphorylation of its receptor, the Met tyrosine kinase, on two carboxyl-terminal tyrosines. These phosphotyrosines (Y1349VHVNATY1356VNV) are multifunctional docking sites for several effectors. Grb2, the adaptor for the Ras guanyl-nucleotide exchanger SOS, binds to Tyr1356 in the YVNV motif. By site-directed mutagenesis we either abrogated or duplicated the Grb2 consensus, without interfering with the other effectors. Loss of the link with Grb2 severely impaired transformation. The same mutation, however, had no effect on the "scattering" response, indicating that the level of signal which can be reached by Grb2-independent routes is permissive for motility. Duplication of the Grb2 binding site enhanced transformation and left motility unchanged. Thus, two Met-mediated biological responses, motility and growth, can be dissociated on the basis of their differential requirement for a direct link with Ras.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8662889     DOI: 10.1074/jbc.271.24.14119

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  34 in total

Review 1.  HGF/SF in mammary epithelial growth and morphogenesis: in vitro and in vivo models.

Authors:  T Kamalati; B Niranjan; J Yant; L Buluwela
Journal:  J Mammary Gland Biol Neoplasia       Date:  1999-01       Impact factor: 2.673

2.  The multisubstrate docking site of the MET receptor is dispensable for MET-mediated RAS signaling and cell scattering.

Authors:  D Tulasne; R Paumelle; K M Weidner; B Vandenbunder; V Fafeur
Journal:  Mol Biol Cell       Date:  1999-03       Impact factor: 4.138

Review 3.  Invasive growth: from development to metastasis.

Authors:  Paolo M Comoglio; Livio Trusolino
Journal:  J Clin Invest       Date:  2002-04       Impact factor: 14.808

4.  Negative feedback regulation of Met-dependent invasive growth by Notch.

Authors:  M Cristina Stella; Livio Trusolino; Selma Pennacchietti; Paolo M Comoglio
Journal:  Mol Cell Biol       Date:  2005-05       Impact factor: 4.272

5.  Selected reaction monitoring mass spectrometry reveals the dynamics of signaling through the GRB2 adaptor.

Authors:  Nicolas Bisson; D Andrew James; Gordana Ivosev; Stephen A Tate; Ron Bonner; Lorne Taylor; Tony Pawson
Journal:  Nat Biotechnol       Date:  2011-06-26       Impact factor: 54.908

6.  A direct role for Met endocytosis in tumorigenesis.

Authors:  Carine Joffre; Rachel Barrow; Ludovic Ménard; Véronique Calleja; Ian R Hart; Stéphanie Kermorgant
Journal:  Nat Cell Biol       Date:  2011-06-05       Impact factor: 28.824

7.  Distinct involvement of the Gab1 and Grb2 adaptor proteins in signal transduction by the related receptor tyrosine kinases RON and MET.

Authors:  Amitabha Chaudhuri; Ming-Hong Xie; Becky Yang; Kaushiki Mahapatra; Jinfeng Liu; Scot Marsters; Sweta Bodepudi; Avi Ashkenazi
Journal:  J Biol Chem       Date:  2011-07-22       Impact factor: 5.157

8.  ErbB4 isoforms selectively regulate growth factor induced Madin-Darby canine kidney cell tubulogenesis.

Authors:  Fenghua Zeng; Ming-Zhi Zhang; Amar B Singh; Roy Zent; Raymond C Harris
Journal:  Mol Biol Cell       Date:  2007-08-29       Impact factor: 4.138

Review 9.  MET receptor tyrosine kinase as an autism genetic risk factor.

Authors:  Yun Peng; Matthew Huentelman; Christopher Smith; Shenfeng Qiu
Journal:  Int Rev Neurobiol       Date:  2013       Impact factor: 3.230

10.  MUC20 suppresses the hepatocyte growth factor-induced Grb2-Ras pathway by binding to a multifunctional docking site of met.

Authors:  Toshio Higuchi; Takuya Orita; Ken Katsuya; Yoshiki Yamasaki; Kiyotaka Akiyama; Huiping Li; Tadashi Yamamoto; Yutaka Saito; Motonao Nakamura
Journal:  Mol Cell Biol       Date:  2004-09       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.